English

ProPhase Labs, Inc.

EDGAR

PRPH Quarterly report (10-Q) · filed 2026-08-19

Annual consolidated revenue for 2025: about USD 4.345M, using the latest reported figures. The previous period, 2024, was about USD 6.77M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.01 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 1011000 USD Source

Operating margin

-261.62%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -2645000 USD Source
Revenue: 1011000 USD Source

Operating cash flow

-78 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -826000 USD Source
Operating Cash Flow: -748000 USD Source

Cash and cash equivalents: 20 thousand USD 2026-06-30 Source
Exact value

20000 USD
Long-term debt including current maturities: 1.6 million USD 2015-12-31 Source
Exact value

1600000 USD
Shares outstanding: 14 million shares 2026-06-30 Source
Exact value

14016024 shares

Reported share-count change

-66.26% · -27.5 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

41541205 shares · 2025-06-30· Source
14016024 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

3.85 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 883000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 4345000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 3561000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 1169000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 1011000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-22.5 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -6839000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -14743000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -7345000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -5175000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -3051000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-5.54 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -7114000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -3628000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -8344000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -7114000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -748000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -826000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -748000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

189 thousand USD

2018-07-01 – 2019-06-30

Exact inputs and evidence

Capital expenditure: 24000 USD · 2018-01-01 – 2018-09-30 Source
Capital expenditure: 24000 USD · 2018-01-01 – 2018-06-30 Source
Capital expenditure: 140000 USD · 2018-01-01 – 2018-12-31 Source
Capital expenditure: 24000 USD · 2018-01-01 – 2018-09-30 Source
Capital expenditure: 48000 USD · 2019-01-01 – 2019-03-31 Source
Capital expenditure: 73000 USD · 2019-01-01 – 2019-06-30 Source
Capital expenditure: 48000 USD · 2019-01-01 – 2019-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-19.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 4 of 11 periods available· newest 2018-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 8 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2015-12-31
Shares outstanding: 6 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-35.8%

Prior period

USD 6.77 million

2024-01-01 – 2024-12-31
Current period

USD 4.35 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

4345000 − 6770000 = -2425000 USD

6770000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
4345000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ProPhase Labs, Inc. · 2025-12-31 ProPhase Labs, Inc. (edgar:868278) Year-over-year change in Revenue: -2425000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 4345000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827826000005/prph-20251231.htm#1494778 Filing: 000086827826000005 Input fundies:Revenue: 6770000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827826000005/prph-20251231.htm#1495434 Filing: 000086827826000005
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 38.62 million

Prior period

−USD 53.36 million

2024-01-01 – 2024-12-31
Current period

−USD 14.74 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-14743000 − -53364000 = 38621000 USD

-53364000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-14743000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ProPhase Labs, Inc. · 2025-12-31 ProPhase Labs, Inc. (edgar:868278) Year-over-year change in Net income: 38621000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -14743000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827826000005/prph-20251231.htm#1540594 Filing: 000086827826000005 Input fundies:NetIncome: -53364000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827826000005/prph-20251231.htm#1541446 Filing: 000086827826000005
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 9.19 million

Prior period

−USD 17.54 million

2024-01-01 – 2024-12-31
Current period

−USD 8.34 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-8344000 − -17538000 = 9194000 USD

-17538000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-8344000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ProPhase Labs, Inc. · 2025-12-31 ProPhase Labs, Inc. (edgar:868278) Year-over-year change in Operating cash flow: 9194000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -8344000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827826000005/prph-20251231.htm#810358 Filing: 000086827826000005 Input fundies:OperatingCashFlow: -17538000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827826000005/prph-20251231.htm#811019 Filing: 000086827826000005
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 4.35 million 100% of revenue
Cost of revenue USD 2.96 million 68% of revenue
Operating expenses USD 19.43 million 447% of revenue
Operating income −USD 18.05 million −415% of revenue
Tax, interest and other Derived −USD 3.3 million −76% of revenue
Net income −USD 14.74 million −339% of revenue

Cash

Operating cash flow −USD 8.34 million −192% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 163% of revenue.
2017 Operating loss: operating costs were 140% of revenue.
2018 Operating loss: operating costs were 112% of revenue.
2019 Operating loss: operating costs were 133% of revenue.
2020 Operating loss: operating costs were 114% of revenue.
2021 88%
2022 15%81%
2023 Operating loss: operating costs were 161% of revenue.
2024 Operating loss: operating costs were 671% of revenue.
2025 Operating loss: operating costs were 515% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	4206000	6862000 Derived	-2656000	212000 Derived	-2868000	-1123000 Derived	Source 2016-01-01 – 2016-12-31: 4206000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -2656000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -2868000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -472000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 651000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	9867000	13857000 Derived	-3990000	-44579000 Derived	40589000	-3046000 Derived	Source 2017-01-01 – 2017-12-31: 9867000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -3990000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: 40589000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -2838000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 208000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	13126000	14760000 Derived	-1634000	106000 Derived	-1740000	-2259000 Derived	Source 2018-01-01 – 2018-12-31: 13126000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -1634000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -1740000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -2119000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 140000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	9876000	13115000 Derived	-3239000	-93000 Derived	-3146000	Unavailable	Source 2019-01-01 – 2019-12-31: 9876000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -3239000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -3146000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -841000 USD Inspect Operating Cash Flow Open source
2020 2020-01-01 – 2020-12-31	14514000	16595000 Derived	-2081000	44000 Derived	-2125000	Unavailable	Source 2020-01-01 – 2020-12-31: 14514000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -2081000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -2125000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -2592000 USD Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	79042000	69241000 Derived	9801000	3528000 Derived	6273000	Unavailable	Source 2021-01-01 – 2021-12-31: 79042000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 9801000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 6273000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -13619000 USD Inspect Operating Cash Flow Open source
2022 2022-01-01 – 2022-12-31	122647000	99052000 Derived	23595000	5132000 Derived	18463000	Unavailable	Source 2022-01-01 – 2022-12-31: 122647000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: 23595000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 18463000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: 28551000 USD Inspect Operating Cash Flow Open source
2023 2023-01-01 – 2023-12-31	34984000	56204000 Derived	-21220000	-4438000 Derived	-16782000	Unavailable	Source 2023-01-01 – 2023-12-31: 34984000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -21220000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -16782000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -11888000 USD Inspect Operating Cash Flow Open source
2024 2024-01-01 – 2024-12-31	6770000	45399000 Derived	-38629000	14735000 Derived	-53364000	Unavailable	Source 2024-01-01 – 2024-12-31: 6770000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -38629000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -53364000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -17538000 USD Inspect Operating Cash Flow Open source
2025 2025-01-01 – 2025-12-31	4345000	22392000 Derived	-18047000	-3304000 Derived	-14743000	Unavailable	Source 2025-01-01 – 2025-12-31: 4345000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -18047000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -14743000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -8344000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4.3M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	4206000	Revenue: 4206000 Open source
20172017-12-31	Revenue	9867000	Revenue: 9867000 Open source
20182018-12-31	Revenue	13126000	Revenue: 13126000 Open source
20192019-12-31	Revenue	9876000	Revenue: 9876000 Open source
20202020-12-31	Revenue	14514000	Revenue: 14514000 Open source
20212021-12-31	Revenue	79042000	Revenue: 79042000 Open source
20222022-12-31	Revenue	122647000	Revenue: 122647000 Open source
20232023-12-31	Revenue	34984000	Revenue: 34984000 Open source
20242024-12-31	Revenue	6770000	Revenue: 6770000 Open source
20252025-12-31	Revenue	4345000	Revenue: 4345000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-35.8% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	67%	Revenue: 4206000 Open source Revenue: 2518000 Open source
20172017-12-31	Year over year	134.6%	Revenue: 9867000 Open source Revenue: 4206000 Open source
20182018-12-31	Year over year	33%	Revenue: 13126000 Open source Revenue: 9867000 Open source
20192019-12-31	Year over year	-24.8%	Revenue: 9876000 Open source Revenue: 13126000 Open source
20202020-12-31	Year over year	47%	Revenue: 14514000 Open source Revenue: 9876000 Open source
20212021-12-31	Year over year	444.6%	Revenue: 79042000 Open source Revenue: 14514000 Open source
20222022-12-31	Year over year	55.2%	Revenue: 122647000 Open source Revenue: 79042000 Open source
20232023-12-31	Year over year	-71.5%	Revenue: 34984000 Open source Revenue: 122647000 Open source
20242024-12-31	Year over year	-80.6%	Revenue: 6770000 Open source Revenue: 34984000 Open source
20252025-12-31	Year over year	-35.8%	Revenue: 4345000 Open source Revenue: 6770000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -415.4% 2025

Net margin -339.3% 2025

Free cash flow margin -17.2% 2018

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	-63.1%	Operating Income: -2656000 Open source Revenue: 4206000 Open source
20172017-12-31	Operating margin	-40.4%	Operating Income: -3990000 Open source Revenue: 9867000 Open source
20182018-12-31	Operating margin	-12.4%	Operating Income: -1634000 Open source Revenue: 13126000 Open source
20192019-12-31	Operating margin	-32.8%	Operating Income: -3239000 Open source Revenue: 9876000 Open source
20202020-12-31	Operating margin	-14.3%	Operating Income: -2081000 Open source Revenue: 14514000 Open source
20212021-12-31	Operating margin	12.4%	Operating Income: 9801000 Open source Revenue: 79042000 Open source
20222022-12-31	Operating margin	19.2%	Operating Income: 23595000 Open source Revenue: 122647000 Open source
20232023-12-31	Operating margin	-60.7%	Operating Income: -21220000 Open source Revenue: 34984000 Open source
20242024-12-31	Operating margin	-570.6%	Operating Income: -38629000 Open source Revenue: 6770000 Open source
20252025-12-31	Operating margin	-415.4%	Operating Income: -18047000 Open source Revenue: 4345000 Open source
20162016-12-31	Net margin	-68.2%	Net Income: -2868000 Open source Revenue: 4206000 Open source
20172017-12-31	Net margin	411.4%	Net Income: 40589000 Open source Revenue: 9867000 Open source
20182018-12-31	Net margin	-13.3%	Net Income: -1740000 Open source Revenue: 13126000 Open source
20192019-12-31	Net margin	-31.9%	Net Income: -3146000 Open source Revenue: 9876000 Open source
20202020-12-31	Net margin	-14.6%	Net Income: -2125000 Open source Revenue: 14514000 Open source
20212021-12-31	Net margin	7.9%	Net Income: 6273000 Open source Revenue: 79042000 Open source
20222022-12-31	Net margin	15.1%	Net Income: 18463000 Open source Revenue: 122647000 Open source
20232023-12-31	Net margin	-48%	Net Income: -16782000 Open source Revenue: 34984000 Open source
20242024-12-31	Net margin	-788.2%	Net Income: -53364000 Open source Revenue: 6770000 Open source
20252025-12-31	Net margin	-339.3%	Net Income: -14743000 Open source Revenue: 4345000 Open source
20162016-12-31	Free cash flow margin	-26.7%	Revenue: 4206000 Open source Operating Cash Flow: -472000 Open source Capital Expenditure: 651000 Open source
20172017-12-31	Free cash flow margin	-30.9%	Revenue: 9867000 Open source Operating Cash Flow: -2838000 Open source Capital Expenditure: 208000 Open source
20182018-12-31	Free cash flow margin	-17.2%	Revenue: 13126000 Open source Operating Cash Flow: -2119000 Open source Capital Expenditure: 140000 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 9876000 Open source Operating Cash Flow: -841000 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 14514000 Open source Operating Cash Flow: -2592000 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 79042000 Open source Operating Cash Flow: -13619000 Open source
20222022-12-31	Free cash flow margin	Not reported	Revenue: 122647000 Open source Operating Cash Flow: 28551000 Open source
20232023-12-31	Free cash flow margin	Not reported	Revenue: 34984000 Open source Operating Cash Flow: -11888000 Open source
20242024-12-31	Free cash flow margin	Not reported	Revenue: 6770000 Open source Operating Cash Flow: -17538000 Open source
20252025-12-31	Free cash flow margin	Not reported	Revenue: 4345000 Open source Operating Cash Flow: -8344000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -8.3M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-472000	Operating Cash Flow: -472000 Open source
20172017-12-31	Operating cash flow	-2838000	Operating Cash Flow: -2838000 Open source
20182018-12-31	Operating cash flow	-2119000	Operating Cash Flow: -2119000 Open source
20192019-12-31	Operating cash flow	-841000	Operating Cash Flow: -841000 Open source
20202020-12-31	Operating cash flow	-2592000	Operating Cash Flow: -2592000 Open source
20212021-12-31	Operating cash flow	-13619000	Operating Cash Flow: -13619000 Open source
20222022-12-31	Operating cash flow	28551000	Operating Cash Flow: 28551000 Open source
20232023-12-31	Operating cash flow	-11888000	Operating Cash Flow: -11888000 Open source
20242024-12-31	Operating cash flow	-17538000	Operating Cash Flow: -17538000 Open source
20252025-12-31	Operating cash flow	-8344000	Operating Cash Flow: -8344000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -2.3M 2018

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-1123000	Operating Cash Flow: -472000 Open source Capital Expenditure: 651000 Open source
20172017-12-31	Free cash flow	-3046000	Operating Cash Flow: -2838000 Open source Capital Expenditure: 208000 Open source
20182018-12-31	Free cash flow	-2259000	Operating Cash Flow: -2119000 Open source Capital Expenditure: 140000 Open source
20192019-12-31	Free cash flow	Unavailable	Operating Cash Flow: -841000 Open source
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -2592000 Open source
20212021-12-31	Free cash flow	Unavailable	Operating Cash Flow: -13619000 Open source
20222022-12-31	Free cash flow	Unavailable	Operating Cash Flow: 28551000 Open source
20232023-12-31	Free cash flow	Unavailable	Operating Cash Flow: -11888000 Open source
20242024-12-31	Free cash flow	Unavailable	Operating Cash Flow: -17538000 Open source
20252025-12-31	Free cash flow	Unavailable	Operating Cash Flow: -8344000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

94.1% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2016-12-31	Liabilities / assets	Not reported	Total Assets: 12802000 Open source
2017-12-31	Liabilities / assets	Not reported	Total Assets: 33659000 Open source
20182018-12-31	Liabilities / assets	20.4%	Total Liabilities: 4233000 Open source Total Assets: 20737000 Open source
20192019-12-31	Liabilities / assets	8.5%	Total Liabilities: 1043000 Open source Total Assets: 12274000 Open source
20202020-12-31	Liabilities / assets	66.4%	Total Liabilities: 20849000 Open source Total Assets: 31405000 Open source
20212021-12-31	Liabilities / assets	34.3%	Total Liabilities: 30667000 Open source Total Assets: 89295000 Open source
20222022-12-31	Liabilities / assets	27.4%	Total Liabilities: 24017000 Open source Total Assets: 87648000 Open source
20232023-12-31	Liabilities / assets	46.3%	Total Liabilities: 42544000 Open source Total Assets: 91927000 Open source
20242024-12-31	Liabilities / assets	88.4%	Total Liabilities: 55847000 Open source Total Assets: 63200000 Open source
20252025-12-31	Liabilities / assets	94.1%	Total Liabilities: 56363000 Open source Total Assets: 59871000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.06× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	1.41×	Current Assets: 9627000 Open source Current Liabilities: 6840000 Open source
20172017-12-31	Current assets / current liabilities	15.68×	Current Assets: 28417000 Open source Current Liabilities: 1812000 Open source
20182018-12-31	Current assets / current liabilities	4.31×	Current Assets: 18238000 Open source Current Liabilities: 4233000 Open source
20192019-12-31	Current assets / current liabilities	10.66×	Current Assets: 9945000 Open source Current Liabilities: 933000 Open source
20202020-12-31	Current assets / current liabilities	2.52×	Current Assets: 15887000 Open source Current Liabilities: 6294000 Open source
20212021-12-31	Current assets / current liabilities	3.95×	Current Assets: 61317000 Open source Current Liabilities: 15524000 Open source
20222022-12-31	Current assets / current liabilities	3.78×	Current Assets: 60833000 Open source Current Liabilities: 16075000 Open source
20232023-12-31	Current assets / current liabilities	2.28×	Current Assets: 47585000 Open source Current Liabilities: 20857000 Open source
20242024-12-31	Current assets / current liabilities	0.95×	Current Assets: 30637000 Open source Current Liabilities: 32134000 Open source
20252025-12-31	Current assets / current liabilities	0.06×	Current Assets: 3150000 Open source Current Liabilities: 53081000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 2.87 million Exact value Exact value: -2868000 USD 2016-01-01 – 2016-12-31: -2868000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ProPhase Labs, Inc. · 2016-12-31 ProPhase Labs, Inc. (edgar:868278) Net Income: -2868000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2868000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315218012362/prph-20171231.xml#142929 Filing: 000149315218012362 The citation records this snapshot. The page link may show a newer release later.	−USD 472,000 Exact value Exact value: -472000 USD 2016-01-01 – 2016-12-31: -472000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ProPhase Labs, Inc. · 2016-12-31 ProPhase Labs, Inc. (edgar:868278) Operating Cash Flow: -472000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -472000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315218012362/prph-20171231.xml#733827 Filing: 000149315218012362 The citation records this snapshot. The page link may show a newer release later.	USD 651,000 Exact value Exact value: 651000 USD 2016-01-01 – 2016-12-31: 651000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ProPhase Labs, Inc. · 2016-12-31 ProPhase Labs, Inc. (edgar:868278) Capital Expenditure: 651000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 651000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315218012362/prph-20171231.xml#736164 Filing: 000149315218012362 The citation records this snapshot. The page link may show a newer release later.	−USD 1.12 million Calculation and evidence -472000 − 651000 USD Exact free cash flow: -1123000 USD 2016-01-01 – 2016-12-31: -472000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 651000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ProPhase Labs, Inc. · 2016-12-31 ProPhase Labs, Inc. (edgar:868278) Free cash flow: -1123000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -472000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315218012362/prph-20171231.xml#733827 Filing: 000149315218012362 Input fundies:CapitalExpenditure: 651000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315218012362/prph-20171231.xml#736164 Filing: 000149315218012362 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	USD 40.59 million Exact value Exact value: 40589000 USD 2017-01-01 – 2017-12-31: 40589000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ProPhase Labs, Inc. · 2017-12-31 ProPhase Labs, Inc. (edgar:868278) Net Income: 40589000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: 40589000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315219003946/prph-20181231.xml#134489 Filing: 000149315219003946 The citation records this snapshot. The page link may show a newer release later.	−USD 2.84 million Exact value Exact value: -2838000 USD 2017-01-01 – 2017-12-31: -2838000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ProPhase Labs, Inc. · 2017-12-31 ProPhase Labs, Inc. (edgar:868278) Operating Cash Flow: -2838000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2838000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315219003946/prph-20181231.xml#830191 Filing: 000149315219003946 The citation records this snapshot. The page link may show a newer release later.	USD 208,000 Exact value Exact value: 208000 USD 2017-01-01 – 2017-12-31: 208000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ProPhase Labs, Inc. · 2017-12-31 ProPhase Labs, Inc. (edgar:868278) Capital Expenditure: 208000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 208000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315219003946/prph-20181231.xml#831933 Filing: 000149315219003946 The citation records this snapshot. The page link may show a newer release later.	−USD 3.05 million Calculation and evidence -2838000 − 208000 USD Exact free cash flow: -3046000 USD 2017-01-01 – 2017-12-31: -2838000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 208000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ProPhase Labs, Inc. · 2017-12-31 ProPhase Labs, Inc. (edgar:868278) Free cash flow: -3046000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2838000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315219003946/prph-20181231.xml#830191 Filing: 000149315219003946 Input fundies:CapitalExpenditure: 208000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315219003946/prph-20181231.xml#831933 Filing: 000149315219003946 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 1.74 million Exact value Exact value: -1740000 USD 2018-01-01 – 2018-12-31: -1740000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ProPhase Labs, Inc. · 2018-12-31 ProPhase Labs, Inc. (edgar:868278) Net Income: -1740000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1740000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315220004807/prph-20191231.xml#107287 Filing: 000149315220004807 The citation records this snapshot. The page link may show a newer release later.	−USD 2.12 million Exact value Exact value: -2119000 USD 2018-01-01 – 2018-12-31: -2119000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ProPhase Labs, Inc. · 2018-12-31 ProPhase Labs, Inc. (edgar:868278) Operating Cash Flow: -2119000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2119000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315220004807/prph-20191231.xml#640812 Filing: 000149315220004807 The citation records this snapshot. The page link may show a newer release later.	USD 140,000 Exact value Exact value: 140000 USD 2018-01-01 – 2018-12-31: 140000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ProPhase Labs, Inc. · 2018-12-31 ProPhase Labs, Inc. (edgar:868278) Capital Expenditure: 140000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 140000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315219003946/prph-20181231.xml#831749 Filing: 000149315219003946 The citation records this snapshot. The page link may show a newer release later.	−USD 2.26 million Calculation and evidence -2119000 − 140000 USD Exact free cash flow: -2259000 USD 2018-01-01 – 2018-12-31: -2119000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 140000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ProPhase Labs, Inc. · 2018-12-31 ProPhase Labs, Inc. (edgar:868278) Free cash flow: -2259000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2119000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315220004807/prph-20191231.xml#640812 Filing: 000149315220004807 Input fundies:CapitalExpenditure: 140000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315219003946/prph-20181231.xml#831749 Filing: 000149315219003946 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 3.15 million Exact value Exact value: -3146000 USD 2019-01-01 – 2019-12-31: -3146000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ProPhase Labs, Inc. · 2019-12-31 ProPhase Labs, Inc. (edgar:868278) Net Income: -3146000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3146000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315221007538/prph-20201231.xml#137531 Filing: 000149315221007538 The citation records this snapshot. The page link may show a newer release later.	−USD 841,000 Exact value Exact value: -841000 USD 2019-01-01 – 2019-12-31: -841000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ProPhase Labs, Inc. · 2019-12-31 ProPhase Labs, Inc. (edgar:868278) Operating Cash Flow: -841000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -841000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315221007538/prph-20201231.xml#178372 Filing: 000149315221007538 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−USD 2.13 million Exact value Exact value: -2125000 USD 2020-01-01 – 2020-12-31: -2125000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ProPhase Labs, Inc. · 2020-12-31 ProPhase Labs, Inc. (edgar:868278) Net Income: -2125000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2125000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315222008541/form10-k.htm#2200611 Filing: 000149315222008541 The citation records this snapshot. The page link may show a newer release later.	−USD 2.59 million Exact value Exact value: -2592000 USD 2020-01-01 – 2020-12-31: -2592000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ProPhase Labs, Inc. · 2020-12-31 ProPhase Labs, Inc. (edgar:868278) Operating Cash Flow: -2592000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2592000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000149315222008541/form10-k.htm#1159755 Filing: 000149315222008541 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	USD 6.27 million Exact value Exact value: 6273000 USD 2021-01-01 – 2021-12-31: 6273000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ProPhase Labs, Inc. · 2021-12-31 ProPhase Labs, Inc. (edgar:868278) Net Income: 6273000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 6273000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827823000004/prph-20221231.htm#1761737 Filing: 000086827823000004 The citation records this snapshot. The page link may show a newer release later.	−USD 13.62 million Exact value Exact value: -13619000 USD 2021-01-01 – 2021-12-31: -13619000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ProPhase Labs, Inc. · 2021-12-31 ProPhase Labs, Inc. (edgar:868278) Operating Cash Flow: -13619000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13619000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827823000004/prph-20221231.htm#1075094 Filing: 000086827823000004 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	USD 18.46 million Exact value Exact value: 18463000 USD 2022-01-01 – 2022-12-31: 18463000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ProPhase Labs, Inc. · 2022-12-31 ProPhase Labs, Inc. (edgar:868278) Net Income: 18463000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 18463000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827824000004/prph-20231231.htm#1616436 Filing: 000086827824000004 The citation records this snapshot. The page link may show a newer release later.	USD 28.55 million Exact value Exact value: 28551000 USD 2022-01-01 – 2022-12-31: 28551000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ProPhase Labs, Inc. · 2022-12-31 ProPhase Labs, Inc. (edgar:868278) Operating Cash Flow: 28551000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 28551000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827824000004/prph-20231231.htm#1021725 Filing: 000086827824000004 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2023-01-01 – 2023-12-31	−USD 16.78 million Exact value Exact value: -16782000 USD 2023-01-01 – 2023-12-31: -16782000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ProPhase Labs, Inc. · 2023-12-31 ProPhase Labs, Inc. (edgar:868278) Net Income: -16782000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16782000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827825000003/prph-20241231.htm#1747512 Filing: 000086827825000003 The citation records this snapshot. The page link may show a newer release later.	−USD 11.89 million Exact value Exact value: -11888000 USD 2023-01-01 – 2023-12-31: -11888000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ProPhase Labs, Inc. · 2023-12-31 ProPhase Labs, Inc. (edgar:868278) Operating Cash Flow: -11888000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11888000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827825000003/prph-20241231.htm#1074818 Filing: 000086827825000003 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2024 2024-01-01 – 2024-12-31	−USD 53.36 million Exact value Exact value: -53364000 USD 2024-01-01 – 2024-12-31: -53364000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ProPhase Labs, Inc. · 2024-12-31 ProPhase Labs, Inc. (edgar:868278) Net Income: -53364000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -53364000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827826000005/prph-20251231.htm#1541446 Filing: 000086827826000005 The citation records this snapshot. The page link may show a newer release later.	−USD 17.54 million Exact value Exact value: -17538000 USD 2024-01-01 – 2024-12-31: -17538000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ProPhase Labs, Inc. · 2024-12-31 ProPhase Labs, Inc. (edgar:868278) Operating Cash Flow: -17538000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17538000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827826000005/prph-20251231.htm#811019 Filing: 000086827826000005 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2025 2025-01-01 – 2025-12-31	−USD 14.74 million Exact value Exact value: -14743000 USD 2025-01-01 – 2025-12-31: -14743000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ProPhase Labs, Inc. · 2025-12-31 ProPhase Labs, Inc. (edgar:868278) Net Income: -14743000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14743000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827826000005/prph-20251231.htm#1540594 Filing: 000086827826000005 The citation records this snapshot. The page link may show a newer release later.	−USD 8.34 million Exact value Exact value: -8344000 USD 2025-01-01 – 2025-12-31: -8344000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ProPhase Labs, Inc. · 2025-12-31 ProPhase Labs, Inc. (edgar:868278) Operating Cash Flow: -8344000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:18:04Z Snapshot: 4aa329177fe3ac8c721841af718b5b913e83e30f8c26e093819ab13d515f9a34 Dimensions: Consolidated View: https://fundies.io/companies/edgar/868278/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8344000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/868278/000086827826000005/prph-20251231.htm#810358 Filing: 000086827826000005 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

154 filings · 5,170 latest values · 5,170 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000868278, 868278, PRPH, edgar:868278, prph

Also known as PROPHASE LABS, INC., ProPhase Labs, Inc., ProPhase Labs, Inc., ProPhase Labs, Inc., QUIGLEY CORP

ProPhase Labs, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation